期刊文献+

羊水细胞染色体核型分析与高龄孕妇年龄因素的相关性 被引量:28

Relationship between fetal karyotype and age of pregnancy
原文传递
导出
摘要 目的通过对高龄孕妇(≥35周岁)染色体核型结果的分析,探讨提高高龄孕妇行羊水细胞遗传学诊断年龄标准的可能性。方法采用回顾性队列研究,分析了2003年7月至2015年8月在宁波市妇女儿童医院细胞遗传室进行羊水细胞染色体检查的5176例高龄孕妇病例资料,选取其中产前筛查检测的目标染色体(13号、18号、21号)以及性染色体X和Y的阳性样本,按年龄分组,利用χ2检验比较相邻的两个年龄组的阳性率的差异。结果在15408份样本中,共发现目标染色体(13号、18号、21号)和性染色体的异常262份,阳性率为1.70%;高龄孕妇共5176例,其中目标染色体(13号、18号、21号)和性染色体异常的82例,阳性率占高龄孕妇的1.58%。统计发现从35岁到〉40岁每个年龄组孕妇的阳性率分别为0.95%(11/1156)、0.94%(9/954)、0.87%(10/1144)、2.16%(14/648)、2.16%(10/464)、2.51%(10/399)和4.38%(18/411),χ2检验显示只有37岁与38岁组的阳性率差异有统计学意义(χ2=5.181,P=0.023),其他各组与前一个年龄组比较后,染色体的阳性率差异无统计学意义χ2值依次为〈0.001、0.028、〈0.001、0.117、2.129,P值依次为0.985、0.868、0.995、0.733、0.145)。结论以38周岁作为孕妇行羊水染色体分析的指征值得探讨。 Objective To evaluate the possibility of elevating the age line for pregnant women with advanced age to conducted amniocentesis. Methods A retrospective cohort study was performed. The information of 5 176 advanced age pregnant women in July 2003 to August 2015 from Ningbo Women and Children Hospital were collected and analyzed. Grouped the patients by age, using chi-square analysis, comparing the difference of abnormal rate of target chromosomes (13, 18, 21 ) and sex chromosomes (X and Y) between the adjacent two age groups. Results Total of 15 408 cases were screened. Among these, 262 cases were diagnosed with abnormal chromosome. The positive rate was 1.70%. Total of 5 176 advanced age pregnant women were included, 82 women were found with abnormal target chromosomes ( 13, 18, 21 ) and sex chromosome. The positive rate was 1.58% (82/5 176). For age groups, the positive rates were 0. 95% (11/1 156), 0. 94% (9/954), 0. 87% (10/1 144), 2.16% ( 14/648), 2. 16% ( 10/464), 2. 51% ( 10/ 399) and 4. 38% (18/411 ) respectively. Chi-square analysis results showed that the positive rate between group of 37 and 38 was significant difference ( chi-square value of 5. 181, P value of 0. 023 ). There were no significant differences among all remained groups ( chi-square value: 〈0. 001, 0. 028, 〈 0. 001, 0. 117, 2. 129 respectively, P value: 0. 985, 0. 868, 0. 995, 0. 733, 0. 145 respectively ). Conclusion It is worthwhile to elevate the age of pregnant women up to 38 years old as the age line for the indications of amniotic fluid chromosome analysis.
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2016年第6期423-426,共4页 Chinese Journal of Laboratory Medicine
基金 浙江省医药卫生科技计划项目(2014KYA200)
关键词 母亲年龄 产前诊断 羊水 染色体 核型分析 年龄因素 Maternal age Prenatal diagnosis Amniotic fluid Chromosomes Karyotyping Age factors
  • 相关文献

参考文献11

二级参考文献41

  • 1戴钟英.重视高龄妇女的妊娠和分娩[J].中国实用妇科与产科杂志,2006,22(10):723-724. 被引量:46
  • 2Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum[ J]. Lancet, 1997,350:485-487.
  • 3Fan HC, Quake SR. Detection of aneuploidy with digital polymerase chain reaction[ J]. Anal Chem,2007,79:7576-7579.
  • 4Lo YM, Lun FM, Chan KC, et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy[ J]. Proe Natl Acad Sei U S A,2007, 104:13116-13121.
  • 5Chiu RW, Akolekar R, Zheng YW, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing:large scale validity study[ J]. BMJ,2011,342 :c7401.
  • 6Ehrieh M, Deeiu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood : a study in a clinical setting[ J]. Am J Obstet Gyneeol 2011,204:205. e1-11.
  • 7Sehnert A J, Rhees B, Comstoek D, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood[ J]. Clin Chem 2011,57:1042-1049.
  • 8Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome : an international clinical validation study [ J ]. Genet Med, 2011,13 : 913-920.
  • 9Sparks AB, Wang ET, Struble CA, et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy[ J]. Prenat Diagn, 2012.32:3-9.
  • 10Wapner R J, Martin CL, Levy B,et al. Chromosomal microarray versus karyotyping for prenatal diagnosis [ J ]. N Engl J Med ,2012,367:2175-2184.

共引文献185

同被引文献182

  • 1张翠玲,李月,杨文庄,张许颖.新冠肺炎疫情对中国出生人口变动的影响[J].人口研究,2021,45(3):88-96. 被引量:28
  • 2王宏,段纯,袁晖,谢建生,赵光临,蓝紫萍.三种母血清产前筛查模式对于21三体综合征筛查效能的比较[J].中华医学遗传学杂志,2019,36(10):1039-1041. 被引量:3
  • 3董媛,张萌,王一鹏,李珊珊,管晓娇,吕巍.从351例胎儿染色体异常的分布探讨高龄孕妇产前筛查及诊断的流程[J].中华医学遗传学杂志,2019,36(6):538-542. 被引量:23
  • 4沈国松,张甦,何平亚,姚娟,沈学萍,薛建英,卢宝庭.779例高龄孕妇的产前筛查与诊断结果分析[J].中国产前诊断杂志(电子版),2009,1(2):29-32. 被引量:22
  • 5Gekas J, Langlois S, RavitskyV, et al. Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues[J]. Appl Clin Genet, 2016, 9: 15-26. DOI: 10. 2147/TACG. S85361.
  • 6Petersen OB, Vogel I, Ekelund C, et al. Potential diagnostic consequences of applying non-invasive prenatal testing : population-based study from a country with existing first-trimester screening[J]. Ultrasound Obstet Gynecol, 2014, 43 (3): 265- 271. DOI: 10. 1002/uog. 13270.
  • 7Brady PD, Vermeesch JR. Genomic microarrays: a technology overviewEJl. Prenat Diagn, 2012, 32(4) : 336-343. DOI: 10. 1002/pd. 2933.
  • 8Miller DT. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[ J]. Am J Hum Genet, 2010, 86 (5) : 749-764. DOI : 10. 1016/j. ajhg. 2010.04. 006.
  • 9Summers AM, Langlois S, Wyatt P, et al. Prenatal screening for fetal aneuploidy. J Obstet Gynecol Can, 2007, 29(2) : 146-179.
  • 10ACOG Committee on Practice Bulletins. ACOG Practice bulletin No. 77 : Screening for fetal chromosomal abnormalities[ J]. Obstet Gynecol, 2007, 109(1):217-227.

引证文献28

二级引证文献151

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部